Chronic Sildenafil Treatment Inhibits Monocrotaline-induced Pulmonary Hypertension in Rats
作者： Ralph T. Schermuly , Klaus P. Kreisselmeier , Hossein A. Ghofrani , Hüseyin Yilmaz , Ghazwan Butrous
DOI: 10.1164/RCCM.200302-282OC
关键词: Internal medicine 、 Pulmonary hypertension 、 Pulmonary heart disease 、 Cardiology 、 Artery 、 Anesthesia 、 Sildenafil 、 Vascular resistance 、 Phosphodiesterase 5 inhibitor 、 Elevated pulmonary artery pressure 、 Medicine 、 Blood pressure
摘要: … The pulmonary vascular resistance index was increased on Day 28 (2.20 ± 0.19 mm Hg min/ml 100 g body weight) and Day 42 (2.44 ± 0.15 mm Hg min/ml 100 g body weight ) (control …
kent.ac.uk
sci-hub.se 参考文章(36)
J. Maruyama, K. Maruyama, Y. Mitani, M. Kitabatake, T. Yamauchi, K. Miyasaka, Continuous low-dose NO inhalation does not prevent monocrotaline-induced pulmonary hypertension in rats American Journal of Physiology-heart and Circulatory Physiology. ,vol. 272, ,(1997) , 10.1152/AJPHEART.1997.272.1.H517
Kyle Northcote Cowan, Adrian Heilbut, Tilman Humpl, Catherine Lam, Shinya Ito, Marlene Rabinovitch, Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor Nature Medicine. ,vol. 6, pp. 698- 702 ,(2000) , 10.1038/76282
Ralph Theo Schermuly, Norbert Weissmann, Beate Enke, Hossein Ardeschir Ghofrani, Wolf Georg Forssmann, Friedrich Grimminger, Werner Seeger, Dieter Walmrath, Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication. American Journal of Respiratory Cell and Molecular Biology. ,vol. 25, pp. 219- 225 ,(2001) , 10.1165/AJRCMB.25.2.4256
H. C. Rosenberg, M. Rabinovitch, Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. American Journal of Physiology-heart and Circulatory Physiology. ,vol. 255, ,(1988) , 10.1152/AJPHEART.1988.255.6.H1484
Hideyuki Adachi, Kohtarou Kodama, Improvement of Mortality by Long-Term E4010 Treatment in Monocrotaline-Induced Pulmonary Hypertensive Rats Journal of Pharmacology and Experimental Therapeutics. ,vol. 290, pp. 748- 752 ,(1999)
John J Lepore, Anjli Maroo, Naveen L Pereira, Leo C Ginns, G.William Dec, Warren M Zapol, Kenneth D Bloch, Marc J Semigran, Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. American Journal of Cardiology. ,vol. 90, pp. 677- 680 ,(2002) , 10.1016/S0002-9149(02)02586-9
Lucie H. Clapp, Paul Finney, Sally Turcato, Sandy Tran, Lewis J. Rubin, Andrew Tinker, Differential Effects of Stable Prostacyclin Analogs on Smooth Muscle Proliferation and Cyclic AMP Generation in Human Pulmonary Artery American Journal of Respiratory Cell and Molecular Biology. ,vol. 26, pp. 194- 201 ,(2002) , 10.1165/AJRCMB.26.2.4695
A. Sebkhi, Julian W. Strange, Steven C. Phillips, John Wharton, Martin R. Wilkins, Phosphodiesterase Type 5 as a Target for the Treatment of Hypoxia-Induced Pulmonary Hypertension Circulation. ,vol. 107, pp. 3230- 3235 ,(2003) , 10.1161/01.CIR.0000074226.20466.B1
THEODORE J. TORPHY, Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. American Journal of Respiratory and Critical Care Medicine. ,vol. 157, pp. 351- 370 ,(1998) , 10.1164/AJRCCM.157.2.9708012
Damian J. Horstman, Deborah U. Frank, George F. Rich, Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats. Anesthesia & Analgesia. ,vol. 86, pp. 74- 81 ,(1998) , 10.1097/00000539-199801000-00015